The completion of the funding round follows Newronika’s recent receival of an IDE from the FDA for the Parkinson’s therapy ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Procyclidine shows promise in reducing nicotine withdrawal symptoms, providing a potential new option for smoking cessation ...
"As the motor symptoms of Parkinson's disease worsen over time, patients report alternating states between ON when their medication is working, and OFF when it's not working optimally," Andrea ...
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment strategies.
The US Food and Drug Administration (FDA) has approved Supernus Pharmaceuticals’ Onapgo (apomorphine hydrochloride) injection ...
Now, scientists in Korea have discovered that the Parkinson’s disease drug procyclidine can alleviate physical symptoms of ...
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in ...
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
and worsening symptoms ("off" times). People with advanced Parkinson’s disease have uncontrollable movements (dyskinesia), making daily tasks difficult. While there’s no cure, current ...